We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ASP RULE OFFERS FEW DETAILS, REQUIRES TOP-LEVEL DATA CERTIFICATION
ASP RULE OFFERS FEW DETAILS, REQUIRES TOP-LEVEL DATA CERTIFICATION
April 6, 2004
The Centers for Medicare & Medicaid Services’ (CMS) long-awaited interim final rule on drugmakers’ submissions of average sales price (ASP) data does little to flesh out the generalities of the Medicare Prescription Drug, Improvement and Modernization Act regarding how to calculate ASP, but high-ranking company officials are still required to certify the accuracy of the data.